Information Provided By:
Fly News Breaks for August 16, 2018
SIEGY, NUVA
Aug 16, 2018 | 06:36 EDT
BTIG analyst Ryan Zimmerman raised his price target on NuVasive (NUVA) to $72 and kept his Buy rating following investor meetings with the management, saying the tone of the discussions was "decidedly more upbeat" after Q2 results and the company's FY18 guidance cut. The analyst states that he also "underappreciated" the potential for NuVasive's recent agreement with Siemens (SIEGY), as it expands the company's opportunity and provides better commercial support. Zimmerman expects investor interest in NuVasive shares to build heading into the full launch of the company's new Pulse system.
News For NUVA;SIEGY From the Last 2 Days
SIEGY
Mar 26, 2024 | 08:06 EDT
Orchestra BioMed announced the appointment of David Pacitti to its Board of Directors, effective as of March 26, 2024. Mr. Pacitti is currently the President of Siemens Medical Solutions USA, Inc. and Head of the Americas, Siemens Healthineers.